2027 NIA Start-Up Challenge and Accelerator: Up to $994,000 in Aging-Technology Prizes

2027 NIA Start-Up Challenge and Accelerator: Up to $994,000 in Aging-Technology Prizes

The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), is opening the fourth cycle of its Start-Up Challenge and Accelerator for early-stage innovators working on the health and well-being of older adults. The program is designed for researchers and other innovators who have a promising science-driven idea but need structured entrepreneurial training, experienced mentors, product-development guidance, and a clearer route toward a small business and future NIH funding.

The submission window opens on December 1, 2026 and closes at 11:59 p.m. Eastern Time on January 15, 2027. NIA plans an informational webinar for December 3, 2026, at 1:00 p.m. ET. The submission link is expected to appear on the official Start-Up Challenge page when registration opens, so a person preparing now should use the announcement period to assemble the core concept rather than waiting for the form to appear.

The financial opportunity has two stages. NIA will select up to 21 Stage 1 finalists, each eligible for a $24,000 cash prize and a five-month accelerator. Up to seven of those finalists can later receive as much as $70,000 each in Stage 2. If all listed awards are made, the total cash pool is up to $994,000. The program also includes entrepreneurial education, one-to-one mentorship, pitch coaching, networking, SBIR application coaching, and access to NIA Entrepreneurs in Residence for business, regulatory, and reimbursement consultations.

Key details at a glance

The amounts are prize amounts, not an NIH research grant. Participation also does not guarantee a future SBIR or STTR award. Any later NIH grant application remains subject to its own eligibility rules, peer review, competition, and award requirements.

What the challenge offers

Stage 1 is intended to help a finalist turn an early idea into a more credible product and business proposition. Each finalist receives $24,000, an opportunity to participate in the five-month accelerator, coaching on the NIH SBIR application process, and access to NIA Entrepreneurs in Residence. NIA describes the consultations as covering business, regulatory, and reimbursement questions, which are often difficult for a research team to answer without outside experience.

The program also provides entrepreneurial training led by industry experts, one-to-one mentorship from founders and investors, in-depth pitch coaching, and virtual and in-person networking with industry partners. These benefits matter because the challenge is not simply asking for a polished laboratory result. Reviewers want to see why the applicant needs this particular combination of money, training, and relationships at the current stage of development.

Stage 2 is a second, more demanding opportunity within the same program. Up to seven finalists may receive up to $70,000 each. To compete for that prize, a finalist must form a company eligible to apply for an NIH SBIR/STTR grant, meet with an NIH program officer about a potential SBIR/STTR proposal by November 1, 2027, complete the required entrepreneurship training, and submit a one-page impact document plus a seven-minute pitch video. The larger award is therefore tied to evidence of progress, not just the quality of the initial idea.

The program fits someone moving from research or technical insight toward a testable product, company, and commercialization plan. It is less suitable for a mature company seeking ordinary growth capital or an applicant looking only for unrestricted research funding.

What kinds of ideas fit

NIA is looking for tools, technologies, and interventions that can prevent, diagnose, treat, monitor, or slow age-related diseases and conditions. Alzheimer’s disease and related dementias are explicitly included, but they are not the only areas of interest. A concept can also focus on healthy aging, aging in place, better care delivery, or reducing the burden on caregivers.

The announcement gives particular attention to artificial intelligence, including data-driven and machine-learning methods for early detection, risk prediction, personalized interventions, and faster drug discovery or development. An AI label alone will not establish fit. A competitive submission should explain the clinical, caregiving, or healthy-aging problem, the evidence supporting the proposed method, and why the approach could be useful across the varied biological, social, behavioral, economic, environmental, and regional circumstances that affect older adults.

The strongest concepts will connect clearly to NIA’s small-business research priorities. A fully commercial product is not required, but the idea must be science-driven, address a real unmet need, and have a plausible path beyond a broad research theme.

Who can apply and key eligibility rules

The challenge accepts submissions from an individual, a team of individuals, or an entity. Individual submitters must be at least 18 years old. A team must designate a Team Lead who registers and submits for the group. An entity must designate a Point of Contact who handles the submission and communications with NIA.

There are important nationality and incorporation limits around prize payment. An individual participating alone must be a U.S. citizen or permanent resident. A team may include non-U.S. citizens and non-permanent residents, but the Team Lead must be a U.S. citizen or permanent resident for the team to receive a cash prize. A private entity must be incorporated in the United States and maintain its primary place of business there. A non-U.S. team member can contribute to a winning team but is not eligible to receive a monetary prize personally under the stated rules.

The rules also exclude a principal investigator on an active NIH SBIR/STTR award at the end of the submission period, a finalist from a previous version of the NIA Start-Up Challenge, federal entities, federal employees acting within the scope of employment, and HHS employees acting in a personal capacity. Judges and certain people involved in designing or running the challenge, along with immediate family members covered by the rules, are also excluded. Federal employees outside HHS should consult their agency ethics official before participating.

Every participant must already have, or intend to form by November 1, 2027, a U.S.-owned and operated small business eligible for NIH SBIR/STTR funding. The challenge is intended to prepare early-stage innovators for venture formation and future small-business research funding, not simply award a one-time idea prize.

How to apply

The submission link is scheduled to open on December 1, 2026, on the official Start-Up Challenge webpage. NIA says applicants can register as an individual, a team, or an entity. The submission must be received by 11:59 p.m. ET on January 15, 2027, and late submissions will not be accepted. The announcement also says that multiple submissions are allowed, but only one submission from each individual, team, or entity can be selected as a finalist.

The public announcement does not yet provide the 2027 form fields because the link is scheduled to open later. Applicants should therefore treat the official form and full challenge announcement as controlling once available. Do not send confidential or proprietary information unless the final instructions expressly permit it. The NIH announcement warns that submitted materials may be published in whole or in part on an NIH website.

For a team, agree on the Team Lead before registration; the lead manages sponsor communications and receives the full team prize. For an entity, confirm submission authority and the information needed for payment. NIA encourages entities to obtain a free Unique Entity ID through SAM.gov because it can expedite payment, although a UEI is not required.

Attend the December 3 informational webinar if possible. NIA says it will explain the challenge, answer questions, and offer application tips. Send remaining questions to [email protected] rather than relying on old guidance from the 2025 cycle.

How applications are reviewed

NIA uses several review stages. Program staff first check eligibility and programmatic relevance and assign an initial score. Submissions with competitive preliminary scores move to technical review, where reviewers with experience in aging research, life-science entrepreneurship, investment, business development, and product development score the proposals. Federal judges then review the submissions and technical evaluations, and NIA staff may conduct screening calls before recommending up to 21 finalists.

Stage 1 has 100 possible points. Significance is worth 15 points and asks whether the product addresses an important unmet need among older adults and whether the scientific premise supports the idea. Innovation is worth 15 points and covers novelty, competitive advantage, and room for refinement. Commercialization is worth 10 points and asks whether there is a defined market and a business strategy with a credible chance of success.

The submitter or team receives 10 points. Reviewers want to understand the commitment, collaboration, and relevant expertise of the people doing the work. Challenge impact on the submitter is worth 25 points, making it important to explain why this team specifically needs the accelerator’s training and resources at this stage. The final 25 points concern impact on NIA research and development: the idea should address an underfunded area, an unmet need for older adults, or bring relevant experience and perspectives that strengthen aging-related innovation. NIA expects a submission to demonstrate at least two of those contributions.

These weights suggest a practical structure: lead with the older-adult problem and evidence, then explain what is new, who would use it, how it could become a product, why the team can advance it, and what the prize would make possible next.

Materials and preparation strategy

Because the final 2027 form is not yet open, prepare a concise application packet that can be adapted to the official prompts. Start with a plain-language problem statement: who is affected, what is not working now, and what outcome would improve. Add the scientific basis for the concept, the current development stage, and the next experiment, prototype, pilot, or validation step that would reduce the biggest uncertainty.

Map the idea against NIA’s priorities and check NIH RePORTER for related NIA SBIR/STTR awards. This shows that you understand the field, can distinguish your product from alternatives, and know where it fills a gap. A short comparison table is more useful than broad claims that the product is revolutionary.

Prepare a team map covering the scientific, technical, clinical, regulatory, product, and business responsibilities. If a capability is missing, explain how a mentor, contractor, co-founder, advisor, or future hire would fill it. Honest awareness of gaps is stronger than pretending the team has every skill.

For the money request, connect each proposed use to a milestone. For example, explain whether the prize would fund prototype work, pilot data, customer discovery, regulatory preparation, or a key hire. Avoid presenting a shopping list with no measurable result. Stage 2 reviewers will later ask how prize funds could expand the team, collect pilot data, secure customers, or raise additional funds, so begin tracking those links during Stage 1.

Finally, practice an explanation that an aging researcher, investor, and older-adult advocate could all understand. Stage 2 requires a seven-minute pitch video, and the criteria include pitch delivery alongside significance, innovation, commercialization, and team strength.

Common mistakes to avoid

Do not describe the opportunity as a guaranteed NIH grant. NIA explicitly says that participation and selection as a winner do not affect decisions on later SBIR/STTR applications. Treat the challenge as prize funding and venture-building support that may improve readiness for a separate competitive grant process.

Do not apply with a generic aging theme and no product path. “Improve senior health” is a mission statement, not a submission. Name the user, the unmet need, the proposed intervention, the evidence, and the next development step.

Do not hide the nationality or company issue until the end. If the lead cannot receive a cash prize, reorganize the team or designate an eligible lead before submitting. If the entity is not incorporated in the United States, treat later company formation as a Stage 2 condition, not a detail to ignore.

Do not overstate novelty or submit confidential trade secrets. Reviewers will compare the idea with research and commercial products, while the official announcement says submitted materials may be published. State what is different, for whom, and why it matters, and obtain intellectual-property advice before disclosing information that cannot be made public.

Frequently asked questions

Is this a grant or an accelerator?

It is a federal prize competition with a five-month accelerator. Stage 1 finalists receive $24,000 each, and up to seven Stage 2 winners can receive up to $70,000 each. The program also offers training, mentoring, networking, and commercialization support. It is not itself an NIH SBIR/STTR grant.

Can a non-U.S. researcher participate?

Yes, a non-U.S. citizen or non-permanent resident may participate as a member of a team that otherwise meets the rules. That person is not eligible to receive a monetary prize personally. The team lead receiving a team prize must be a U.S. citizen or permanent resident, and an entity receiving a prize must be U.S.-incorporated with a U.S. primary place of business.

Does a team need an existing company at the time of application?

Not necessarily. Participants certify that they have already formed, or intend to form by November 1, 2027, a U.S.-owned and operated small business eligible to apply for NIH SBIR/STTR funding. Stage 2 finalists must meet the company-formation and NIH program-officer requirements by the stated deadline.

What must Stage 2 finalists submit?

They must complete the comprehensive entrepreneurship training, form a qualifying company, meet with an NIH program officer about a potential SBIR/STTR proposal, submit a one-page document describing the prize’s impact, and submit a seven-minute pitch video. NIA also evaluates a mentor assessment at Stage 2.

Does winning guarantee later NIH funding?

No. NIA says that future SBIR/STTR applications remain subject to their own competition, peer review, eligibility, and award requirements. The challenge can help an applicant prepare, but it does not bypass the grant process.

Official links and next steps

Start with NIA’s official 2027 announcement, which confirms the opening date, deadline, benefits, eligibility summary, webinar, and contact email. Review the NIH challenge announcement for the full rules and submission requirements, and read NIA’s judging criteria and prizes page for the scoring weights and award conditions.

Before December 1, write a one-page concept summary, identify the older-adult need, list the closest alternatives, assign team roles, and define the milestone the Stage 1 prize would fund. Confirm the nationality or incorporation requirements, decide who will submit, and register for the December 3 webinar. When the submission form opens, compare every answer with the final official instructions and submit before January 15, 2027 at 11:59 p.m. ET.